SPHINX31


CAS No. : 1818389-84-2

1818389-84-2
Price and Availability of CAS No. : 1818389-84-2
Size Price Stock
5mg $99 In-stock
10mg $132 In-stock
50mg $385 In-stock
100mg $605 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-117661
M.Wt: 507.51
Formula: C27H24F3N5O2
Purity: >98 %
Solubility: DMSO : 17.33 mg/mL (ultrasonic)
Introduction of 1818389-84-2 :

SPHINX31 is a potent and selective SRPK1 inhibitor, with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 also decreases the mRNA expression of pro-angiogenic VEGF-A165a isoform. SPHINX31 can be used to research neovascular eye disease[1][2][3]. IC50 & Target: IC50: 5.9 nM (SRPK1)[1]
VEGF-A165a[2] In Vitro: SPHINX31 (0.3-10 μM; 24 h) significantly down-regulates the expression of VEGF-A165a mRNA[2].
SPHINX31 (0.3 μM; 24 h) suppresses SRSF1 phosphorylation and nuclear localization[2].
SPHINX31 (0.3-10 μM; 24 h) decreases pre-tube formation and the rate of migration for human umbilical vein endothelial cells (HUVECs)[2]. In Vivo: SPHINX31 (200 μg/mL; twice daily topical eye drops) protects the retinal endothelial permeability barrier from diabetes-associated loss of integrity[3].

Your information is safe with us.